Developer of cold plasma delivery system designed to reduce cancer recurrence. The company's patented cold plasma device generates plasma species, producing cellular oxidative stress that kills cancer...

Healthcare
Montreal, Canada
Founded 2008
3 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$570K
Last Round
N/A

Get the full picture

Create a free account to unlock NexPlasmaGen's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required